University of Ottawa Institute of Mental Health Research (S.S., M.E.M., P.B.) and Department of Cellular and Molecular Medicine, University of Ottawa (S.S., P.B.), Ottawa, Ontario, Canada.
J Pharmacol Exp Ther. 2013 Nov;347(2):487-96. doi: 10.1124/jpet.113.203315. Epub 2013 Aug 28.
Carisbamate and lamotrigine are anticonvulsants that act on neuronal voltage-gated sodium channels. Carisbamate has shown antidepressant-like effects in animal models of depression, and lamotrigine is a mood stabilizer with a therapeutic effect in depressive episodes of patients with bipolar disorder. This study examined the effects of carisbamate and lamotrigine on monoaminergic transmission in rodents, which could contribute to their antidepressant action. In vivo electrophysiological recordings were carried out in rats after 2 and 14 days administration of vehicle, carisbamate (60 mg/kg daily), or lamotrigine (25 mg/kg daily). Overall firing activity of the dorsal raphe nucleus (DRN) serotonin (5-HT), locus coeruleus norepinephrine, and ventral tegmental area dopamine (DA) neurons was decreased with carisbamate. Lamotrigine also decreased 5-HT neuronal firing, and this effect was abolished by lesion of the prefrontal cortex. Despite these decreases in firing activity after their prolonged administration, both anticonvulsants exhibited a significant increase in tonic activation of hippocampus 5-HT1A receptors, as shown by a disinhibition of the firing activity of pyramidal neurons in response to the selective antagonist WAY-100635 (N-{2-[4(2-methoxyphenyl)-1-piperazinyl] ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride). This finding reveals an increase in the 5-HT level that may be attributed to a desensitization of the terminal 5-HT1B autoreceptors. This study demonstrates that sustained carisbamate and lamotrigine administration decreases 5-HT firing in the DRN but nevertheless enhances 5-HT transmission in the forebrain. This serotonergic effect may be associated with an antiglutamatergic action and may contribute to the antidepressant-like effect of carisbamate in the forced swim test and the antidepressant properties of lamotrigine.
卡利昔泮和拉莫三嗪是作用于神经元电压门控钠离子通道的抗惊厥药。卡利昔泮在抑郁症动物模型中显示出抗抑郁样作用,拉莫三嗪是一种心境稳定剂,对双相情感障碍患者的抑郁发作有治疗作用。本研究探讨了卡利昔泮和拉莫三嗪对啮齿动物单胺能传递的影响,这可能有助于它们的抗抑郁作用。在给予载体、卡利昔泮(60mg/kg 每日)或拉莫三嗪(25mg/kg 每日)2 天和 14 天后,对大鼠进行体内电生理记录。背侧中缝核(DRN)5-羟色胺(5-HT)、蓝斑去甲肾上腺素和腹侧被盖区多巴胺(DA)神经元的整体放电活性随着卡利昔泮的应用而降低。拉莫三嗪也降低了 5-HT 神经元的放电,而这种作用在前额叶皮质损伤后被消除。尽管在长期给药后这些放电活动减少,但这两种抗惊厥药都显著增加了海马 5-HT1A 受体的紧张性激活,这表现为对选择性拮抗剂 WAY-100635(N-(2-[4(2-甲氧基苯基)-1-哌嗪基]乙基)-N-(2-吡啶基)环己烷甲酰胺三盐酸盐)反应的锥体神经元放电活动的抑制。这一发现揭示了 5-HT 水平的增加,这可能归因于末端 5-HT1B 自身受体的脱敏。本研究表明,持续给予卡利昔泮和拉莫三嗪可降低 DRN 中的 5-HT 放电,但仍能增强前脑的 5-HT 传递。这种 5-HT 能效应可能与抗谷氨酸能作用有关,并可能有助于卡利昔泮在强迫游泳试验中的抗抑郁样作用和拉莫三嗪的抗抑郁特性。